CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION

乳头状病毒晚期转录的控制

基本信息

项目摘要

The papillomaviruses cause benign and malignant lesions of squamous epithelia in higher vertebrates. The complete lytic cycle of these viruses (including late gene expression) occurs only in the differentiated cells of the squamous epithelium. Malignant lesions and infected cells in culture do not produce virus. We have used bovine papillomavirus type 1 (BPV-l) as a model system for the study of papillomavirus late gene expression and its control. Transcriptional mapping data indicates that the late mRNAs which encode the major and minor capsid proteins are expressed from a strong viral transcriptional promoter (called the late promoter) which is active only in productively infected epithelium. Late mRNAs are almost undetectable in nonproductively infected (transformed) cells. Analysis of BPV-1 mutants with deletion of most of the late region demonstrated that the BPV-1 late polyadenylation site can be efficiently utilized even in transformed cells. Eukaryotic expression vectors have also been used to show that the late poly(A) site is a more efficient poly(A) site than the early poly(A) site. The inefficient use of the late poly(A) site when it is positioned in its normal context 3 kb downstream of the early poly(A) site may be due partially to transcription termination or pausing which has been shown to occur between the early and late poly(A) sites in transformed cells and partially to a short inhibitory element in the late 3'UTR. This late 3'UTR element has been shown not to function by destabilizing late mRNAs as was previously thought and may function at an RNA processing or transport level. We also have evidence that BPV-1 poly(A) site choice could be regulated by splicing factors. BPV-1 late promoter transcripts can be spliced into acceptors at nt 3225 or 3605 and this splice site choice is differentially regulated in nonproductively and productively infected cells. We have shown, using transfection studies, that exon sequences between these two splice sites modulate the use of the splice donor at nt 3764. In addition, we have shown that efficient use of the nt 3764 splice site in the absence of these exon sequences can suppress polyadenylation at the early poly(A) site.
乳头状瘤病毒引起良性和恶性的鳞状病变

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

C C BAKER其他文献

C C BAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('C C BAKER', 18)}}的其他基金

REGULATION OF PAPILLOMAVIRUS GENE EXPRESSION
乳头状病毒基因表达的调控
  • 批准号:
    6100812
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION
乳头状病毒晚期转录的控制
  • 批准号:
    3752665
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PAPILLOMAVIRUS TRANSCRIPTIONAL PROGRAM
乳头瘤病毒转录程序
  • 批准号:
    2463666
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CHARACTERIZATION OF THE PAPILLOMAVIRUSES
乳头瘤病毒的特征
  • 批准号:
    2463587
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE GENE EXPRESSION
乳头状病毒晚期基因表达的控制
  • 批准号:
    5201496
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION
乳头状病毒晚期转录的控制
  • 批准号:
    3874683
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF PAPILLOMAVIRUS GENE EXPRESSION
乳头状病毒基因表达的调控
  • 批准号:
    6160912
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION
乳头状病毒晚期转录的控制
  • 批准号:
    3916849
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION
乳头状病毒晚期转录的控制
  • 批准号:
    3963568
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CONTROL OF PAPILLOMAVIRUS LATE TRANSCRIPTION
乳头状病毒晚期转录的控制
  • 批准号:
    3838380
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
  • 批准号:
    10623834
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246530
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246531
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
  • 批准号:
    2882792
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
  • 批准号:
    23K18260
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
  • 批准号:
    10722782
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
  • 批准号:
    23H02688
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
  • 批准号:
    10785159
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
  • 批准号:
    10729566
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
  • 批准号:
    10650417
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了